England Reimbursement Profile

Posted 18 September 2017 By Vishal Patel

placeholder+image This profile summarizes the reimbursement process in England, presents key stakeholders and highlights what should be considered early in the development process.

Share this article:

Categories: Biologics and biotechnology, Drugs, Reimbursement, Features, Europe, MHRA, NICE

Tags: NICE, NHS, Reimbursement

Regulatory Exchange: Latest Updates From the Community